Michelle

Congratulations to the 370 new Fellows and Members conferred yesterday! 👏 Awards were conferred by RCSI and our Faculties of Radiologists and Radiation Oncologists, Dentistry, Nursing and Midwifery and Sports and Exercise Medicine. ➡️ rcsi.com/dublin/news-an… #RCSIConferring

I was surprised by all the interest in our project, a novel approach to titrating long-term oxygen therapy in COPD patients at the @irishthoracicS Conference, with a bonus prize (2nd best poster). @NCPRespiratory1 #RespiratoryNursing

Presented our remote monitoring project to support decision-making towards Long Term oxygen therapy for COPD patients. Also reunited with my OG respiratory team! #RespiratoryNursing #ITSconference2025

Irish Thoracic Society Conference 2025 🇮🇪🫁 Great day with the OLOLH Drogheda Respiratory team and lovely to catch up with colleagues from respiratory services across Ireland. #ITS

Beaumont Hospital Respiratory Airways Team awarded as the Medical Team of Year at the recent Irish Healthcare awards 2025

Exciting times in #Bronchiectasis, with many promising new drugs in development. Delighted to share our new work “Emerging therapies in bronchiectasis”, published today in the European Respiratory Journal @ERSpublications @LPereaS @AlibertiStefano publications.ersnet.org/content/erj/ea…

Alison Resp CNS of Dublin North Central RIC, articulating the social value of Respiratory Integrated Care at the HSE DNE & RCSI Faculty of Nursing and Midwifery 4th Annual Advancing Nursing and Midwifery Practice Grand Rounds #RespiratoryNursing @NCPRespiratory1 @soomeraghsandra

Live at RCSI for the HSE DNE Grand Rounds on Advancing Nursing & Midwifery Practice, with openings from Ms Petrina Donnelly & Ms Ann Lister. #GrandRounds #ANP

IAANMP conference well under way, with the theme ‘A vision on the advanced practice model of care’ been showcased by our inspiring speakers #iaanmpconference2025

Pulmonary function test interpretation

Emerging evidence suggests air pollution may be associated with abnormalities and disease of the alveoli and pulmonary interstitium. This review examines this evidence alongside mechanisms of alveolar injury, susceptibility factors and knowledge gaps. bit.ly/3GsTO1E

In women with asthma, having an asthma exacerbation during pregnancy increases the risk of bronchiolitis and wheeze in infants, whereas inhaled corticosteroid use during pregnancy does not appear to have an impact on wheeze and bronchiolitis outcomes bit.ly/42xX7NH

A landmark Chinese position paper in @AllergyEAACI outlines expert recommendations for biologic therapy in CRSwNP. It provides updated criteria for patient selection, monitoring, and treatment response. Read more: doi.org/10.1111/all.16… #CRSwNP #Biologics #Allergy

ERJ Open Res: Multimorbid severe COPD patients need to be treated with a complementary systemic approach. In this way, the patient, not only the airway disease, will be treated comprehensively, as two effects (metabolic and pulmonary) are better than one. bit.ly/3PHoygt

ERJ Open Research: Triple therapy should be initiated earlier in the course of COPD bit.ly/3Nh9W6j

Anti-IL-5/5Rα biologics reduce severe exacerbations and hospitalisations, improve asthma control, quality of life and lung function, and decrease systemic corticosteroids use in real-life settings; a biomarker-related response to treatment is also noted bit.ly/3MW4JR3

ERR: Electronic inhaler adherence monitoring can effectively identify sub-optimal adherence in people with COPD and potentially improve adherence when combined with healthcare professionals’ interventions. The impact on clinical outcomes remains uncertain. bit.ly/3NfGtK5

European Respiratory Review: This review explores the interface between defective macrophage phagocytosis and distinct changes in the respiratory microbiome observed during COPD, whereby selective uptake of pathogens may be driving community structure. bit.ly/3Mpj7kM

Thank u #bts2024 for asking us to present our analysis of the UK severe asthma registry showing young adults with asthma have much worse outcomes when compared to other age ranges...we need to invest more in this cohort to minimise harm and prevent future complications

ERJ Open Research: Treatment with tezepelumab improved lung function and reduced asthma exacerbations compared with placebo in patients with severe, uncontrolled asthma and persistent airflow obstruction, which can be difficult to treat bit.ly/3XoPkPM